Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

However, Kenya Medical Supplies Agency (Kemsa) CEO Waqo Erjesa said on Wednesday they have sufficient stocks of the HIV ...

In patients with HIV, cancer incidence trends from 2001 to 2019 differed by transmission risk and were not uniform across racial and ethnic groups.

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

Through the Kenya Medical Supplies Authority (KEMSA) Chief Executive Officer Waqo Erjesa, the government confirmed that there ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...